Dual-Agent Eye Drop for Presbyopia
YUVEZZI™ approved for the treatment of presbyopia, blurry close-up vision due to aging
Clinical Scorecard: Dual-Agent Eye Drop for Presbyopia
At a Glance
Category Detail
Condition Presbyopia Key Mechanisms Combination of carbachol and brimonidine tartrate to improve near vision. Target Population Adults experiencing presbyopia, typically starting around age 45. Care Setting Prescribed by eye care professionals, available through e-pharmacy and retail pharmacies.
Key Highlights
YUVEZZI is the first dual-agent eye drop approved for presbyopia. Single drop, once-daily dosing improves near vision. Designed to meet the real-world needs of aging adults. Guideline-Based Recommendations
Diagnosis
Diagnosis of presbyopia typically occurs in adults around age 45. Management
Prescribe YUVEZZI for improved near vision in adults with presbyopia. Monitoring & Follow-up
Monitor patient response to treatment and adjust as necessary. Risks
Evaluate for potential side effects associated with carbachol and brimonidine tartrate. Patient & Prescribing Data
Adults with presbyopia.
YUVEZZI offers a convenient treatment option that reduces reliance on reading glasses.
Clinical Best Practices
Educate patients on the proper use of YUVEZZI. Assess the patient's vision needs and lifestyle when prescribing. Related Resources & Content
